Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Velavigo (Shanghai) Ltd.

Headquarters: Shanghai, China
Year Founded: 2021
Status: Private
BioCentury | Jan 3, 2025
Finance

Ausperbio, Gemmabio, Velavigo tap VCs for cash in late December

In BioCentury’s latest Venture Report, two trans-Pacific companies and a gene therapy newco draw funding
BioCentury | Nov 19, 2024
Deals

More bispecific deals in China: Aclaris/Biosion, Ouro/Keymed, Avenzo/VelaVigo

BioCentury’s Deals Report also includes GSK’s agreement with Flagship-backed Vesalius in Parkinson’s disease, and more
BioCentury | Apr 12, 2024
Product Development

Cambrian explosion of ADCs at AACR24

Conference showcases six emerging ADC payload types, and trends in antigen pairs for bispecific ADCs
BioCentury | Jan 8, 2022
Emerging Company Profile

VelaVigo: Li, Zhang chart course to build global biologics player

WuXi vets’ Shanghai newco focusing on antibody innovation
BioCentury | Dec 18, 2021
Management Tracks

Tong Zhang joins Jing Li at VelaVigo

Plus: Coherus, Allen Institute, Transcenta
Items per page:
1 - 5 of 5